Abstract
The introduction of Positron Emission Tomography (PET) and the use of the glucose analog F-18-Deoxyglucose (FDG) can help to improve the sensitivity of the diagnosis of lymph node metastases. Sensitivity exceeding 90% can be achieved when advanced imaging protocols and image reconstruction methods are used for PET. Superior staging information is obtained with PET as compared to morphological imaging methods for the most frequent tumor types. The accuracy of N-staging can be significantly improved by adding PET to the pretherapeutic diagnostic procedures. Limitations exist with regard to false positive results. Acute or chronic inflammation as well as unspecific reactions following radiotherapy may mimic tumor tissue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Strauss LG, Clorius JH, Schlag P, et al. (1989) Recurrence of colorectal tumors: PET evaluation. Radiology 170:329–332
Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32:623–648
Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, et al. (1998) Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma. J Nucl Med 39:1197–1202
Dimitrakopoulou-Strauss A (1996) Editorial: New approaches for the non invasive quantification of chemotherapeutic drugs in tumors and the evaluation of multidrug resistance. The Cancer Journal 9:118–120
Higashi K, Clavo AC, Wahl RL (1993) Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNAflow cytometry and tritiated thymidine uptake. J Nucl Med 34:414–419
Strauss LG (1996) Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnosis of oncological patients. Eur J Nucl Med 23:1409–1415
Hundt W, Braunschweig R, Reiser M (1999) Evaluation of spiral CT of colon and rectom carcinoma. Eur Radiol 9:78–84
Anzai Y, Brunberg JA, Lufkin RB (1997) Imaging of nodal metastases in the head and neck. J Magn Reson Imaging 7:774–783
Adams S, Baum RP, Stuckensen T, et al. (1998) Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255–1260
Laubenbacher C, Saumweber D, Wagner-Mansiau C, et al. (1995) Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 36:1747–1757
Crippa F, Agresti R, Seregni E, et al. (1998) Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 39:4–8
Avril N, Dose J, Janicke F, Ziegler S, et al. (1996) Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl. Cancer Inst 4:1204–1209
Matthews JI, Richey HM, Helsel RA, et al. (1987) Thoracic computed tomography in the preoperative evaluation of primary bronchogenic carcinoma. Arch Intern Med 147:449–453
Bonomo L, Ciccotosto C, Guidotti A, et al. (1996) Lung cancer staging: the role of computed tomography and magnetic resonance imaging. Eur J Radiol 23:35–45
Strauss LG, Clorius JH, Manke H, et al. (1987) PET in oat cell carcinoma. Radiology 165(P):212
Steinert HC, Hauser M, Allemann F, et al. (1997) Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 202:441–446
Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. (1998) Lymph node staging in nonsmall-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16:2142–2149
Nettelbladt OS, Sundin AE, Valind SO, et al. (1998) Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. J Nucl Med 39:640–647
Steinert HC, Huch Buoni RA, Buck A, et al. (1995) Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 195:705–709
Macfarlane DJ, Sondak V, Johnson T, et al. (1998) Prospective evaluation of 1[F-18]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. J Clin Oncol 16:1770–1776
Holder WD Jr, Whilte RL Jr, Zuger JH, et al. (1998) Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 227:764–769
Steinert HC, Voellmy DR, Trachsel C, et al. (1998) Planar coincidence scintigraphy and PET in staging malignant melanoma. J Nucl Med 39:1892–1897
Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620
Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206:755–760
Engenhart R, Kimmig BN, Strauss LG, et al. (1990) Therapy monitoring of presacral recurrencies after high-dose irradiation. Value of PET, CT, CEA and pain score. Strahlenther Oncol 166:95–98
Minn H, Kangas L, Kellokumpu-Lehtinen P, et al. (1990) Uptake of 2-fluoro-2-deoxy-D[U-(14)C]glucose during chemotherapy in murine Lewis lung tumor. Nucl Med Biol Int J Radiat Appl Instrum 19:55–63
Haberkorn U, Reinhardt M, Strauss LG, et al. (1992) Metabolic design of combined therapy: use of enhanced fluorode oxyglucose uptake caused by chemotherapy. J Nucl Med 33:1981–1987
Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, et al. (1995) Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 22:434–442
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Strauss, L.G. (2000). Sensitivity and Specificity of Positron Emission Tomography (PET) for the Diagnosis of Lymph Node Metastases. In: Schlag, P.M., Veronesi, U. (eds) Lymphatic Metastasis and Sentinel Lymphonodectomy. Recent Results in Cancer Research, vol 157. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57151-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-57151-0_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63070-5
Online ISBN: 978-3-642-57151-0
eBook Packages: Springer Book Archive